Skip to main content

Macrophage-Derived IL-18 Targeting for the Treatment of Crohn's Disease

Buy Article:

$63.00 plus tax (Refund Policy)


Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohn's disease. We here focus on the role of macrophages, especially macrophagederived IL-18 in both patients with Crohn's disease and a murine model of Crohn's disease.

Keywords: crohns disease; il-18; immunotoxin; proinflammatory cytokines; targeting

Document Type: Review Article


Publication date: June 1, 2003

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more